Neonatal Mass Urine Screening Approach for Early Detection of Mucopolysaccharidoses by UPLC-MS/MS
Open Access
- 18 November 2019
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 9 (4) , 195
Abstract
Mucopolysaccharidoses (MPSs) are lysosomal storage disorders caused by deficiencies of enzymes involved in the catabolism of glycosaminoglycans (GAGs). Various treatments such as enzyme replacement therapy and/or hematopoietic stem cell transplant are available for MPSs. Early initiation of treatment improves the outcome and delays the onset of symptoms, highlighting the need for newborn screening for MPSs. The main objective of this project was to devise and validate a multiplex urine filter paper method for GAG analysis using a tandem mass spectrometry (MS/MS) approach to screen newborns for MPSs. Eluted urine samples from 21-day-old newborns were evaporated and a methanolysis reaction was performed. Samples were resuspended and analyzed using a UPLC-MS/MS system. A one-minute chromatographic method allowed the absolute quantification of heparan sulfate (HS), dermatan sulfate (DS), and creatinine. Method validation revealed high precision (< 9% relative standard deviation) and accuracy (< 7% bias) for all analytes. The reference values normalized to creatinine obtained by the analysis of five hundred 21-day-old newborn urine samples were 34.6 +/-6.2 mg/mmol of creatinine and 17.3 +/-3.9 mg/mmol of creatinine for HS and DS, respectively. We present a rapid and efficient method for populational newborn urine screening using MS/MS, which could also be applied to high-risk screening.Keywords
This publication has 28 references indexed in Scilit:
- Pathological and Biochemical Studies of Mucopolysaccharidosis Type IIIB (Sanfilippo Syndrome Type B) in Juvenile Emus (Dromaius novaehollandiae)Veterinary Pathology, 2014
- Glycan-based biomarkers for mucopolysaccharidosesMolecular Genetics and Metabolism, 2014
- Early initiation of enzyme replacement therapy for the mucopolysaccharidosesMolecular Genetics and Metabolism, 2014
- Combination of Injection Volume Calibration by Creatinine and MS Signals’ Normalization to Overcome Urine Variability in LC-MS-Based Metabolomics StudiesAnalytical Chemistry, 2013
- Does early use of enzyme replacement therapy alter the natural history of mucopolysaccharidosis I? Experience in three siblingsMolecular Genetics and Metabolism, 2013
- An improved method for glycosaminoglycan analysis by LC–MS/MS of urine samples collected on filter paperClinica Chimica Acta, 2012
- Overview of the mucopolysaccharidosesRheumatology, 2011
- Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatmentGenetics and Molecular Biology, 2010
- Enzyme-Replacement Therapy in a 5-Month-Old Boy With Attenuated Presymptomatic MPS I: 5-Year Follow-upPediatrics, 2010
- Quebec neonatal mass urinary screening programme: From micromolecules to macromoleculesJournal of Inherited Metabolic Disease, 2007